Literature DB >> 10452513

Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma arising in the subarachnoid space.

S A Ely1, J Powers, D Lewis, S Chang, A Rubio, J O'Leary, D M Knowles.   

Abstract

Primary effusion lymphoma (PEL) is a rare and distinctive type of B-cell non-Hodgkin's lymphoma (NHL) that occurs primarily, although not exclusively, in patients with AIDS. It usually develops as a lymphomatous effusion in the absence of a tumor mass, characteristically contains the Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 (KSHV/HHV-8), usually also contains the Epstein-Barr virus (EBV), displays a characteristic cytomorphology bridging immunoblastic and anaplastic large cell lymphoma, often expresses an indeterminate immunophenotype, and a B-cell genotype. Thus far, PEL has been limited almost entirely to the pleural, peritoneal, and pericardial cavities. We describe a NHL occurring in a gay man with AIDS that is typical of PEL in that it arose in a body cavity or space without an associated tumor mass, displays the cytomorphology typical of PEL, is a clonal B-cell neoplasm, and contains KSHV as well as EBV. This case is singularly distinctive in that it is the first case of PEL reported to arise in the subarachnoid space. This unique case further supports the strong association between KSHV and malignant lymphoma arising in body cavities and growing as an effusion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10452513     DOI: 10.1016/s0046-8177(99)90254-x

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  4 in total

1.  HHV8-related lymphoid proliferations: a broad spectrum of lesions from reactive lymphoid hyperplasia to overt lymphoma.

Authors:  Blanca Gonzalez-Farre; Daniel Martinez; Monica Lopez-Guerra; Marc Xipell; Ester Monclus; Jordina Rovira; Felipe Garcia; Armando Lopez-Guillermo; Luis Colomo; Elias Campo; Antonio Martinez
Journal:  Mod Pathol       Date:  2017-01-13       Impact factor: 7.842

Review 2.  KSHV/HHV8-mediated hematologic diseases.

Authors:  Ethel Cesarman; Amy Chadburn; Paul G Rubinstein
Journal:  Blood       Date:  2022-02-17       Impact factor: 22.113

Review 3.  Primary effusion lymphoma: current perspectives.

Authors:  Mayur Narkhede; Shagun Arora; Chaitra Ujjani
Journal:  Onco Targets Ther       Date:  2018-06-28       Impact factor: 4.147

4.  Human Immunodeficiency Virus-associated primary effusion lymphoma: An exceedingly rare entity in cerebrospinal fluid.

Authors:  Sarika Jain; Alka Palekar; Sara E Monaco; Fiona E Craig; Ghassan Bejjani; Liron Pantanowitz
Journal:  Cytojournal       Date:  2015-10-23       Impact factor: 2.091

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.